US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist

0.5900
-0.0080-1.34%

Close Nov 29 13:00 ET

0.5708
-0.0192-3.25%

Post 16:49 ET

4.01MMarket Cap-464P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

71.69%-185.66K

-1.31%-1.55M

-346.22%-1.66M

-85.76%-3.7M

-532.51%-1.14M

-22.52%-655.77K

-80.83%-1.53M

13.64%-371.83K

28.76%-1.99M

55.33%-180.94K

Net income from continuing operations

54.12%-640.79K

-32.82%-1.61M

-140.12%-1.72M

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

Operating gains losses

--0

-143.33%-51.53K

-104.47%-198

1,268.74%630.32K

7,876.31%483.76K

96.66%23.18K

411.69%118.95K

-10.57%4.43K

156.72%46.05K

143.97%6.07K

Depreciation and amortization

785.98%12.57K

13,714.29%12.57K

13,868.89%12.57K

93,960.00%28.22K

88,626.67%26.62K

--1.42K

--91

--90

--30

Other non cash items

----

-22.59%85.77K

22.72%31.24K

-82.50%4.45K

-24.30%25.18K

-6.49%24.9K

-74.06%110.8K

-47.89%25.45K

Change In working capital

-64.75%192.15K

72.86%-171.83K

-172.69%-109.13K

-121.18%-114.41K

-192.84%-176.58K

294.56%545.11K

-39.94%-633.07K

-77.40%150.13K

484.74%540.13K

-11.86%190.2K

-Change in prepaid assets

-89.96%77.39K

53.49%-400.3K

133.06%100.03K

-113.79%-87.09K

-189.48%-39.95K

1,626.13%770.6K

-545.61%-860.65K

-93.65%42.92K

231.47%631.73K

-60.75%44.64K

-Change in payables and accrued expense

150.89%114.76K

0.39%228.46K

-295.09%-209.16K

70.17%-27.33K

-193.86%-136.63K

-341.14%-225.49K

171.32%227.58K

1,026.72%107.21K

-126.93%-91.6K

42.63%145.56K

Cash from discontinued investing activities

Operating cash flow

71.69%-185.66K

-1.31%-1.55M

-346.22%-1.66M

-85.76%-3.7M

-532.51%-1.14M

-22.52%-655.77K

-80.83%-1.53M

13.64%-371.83K

28.76%-1.99M

55.33%-180.94K

Investing cash flow

Cash flow from continuing investing activities

-0.75%1.6M

308.21%1.2M

199.03%4.78M

1,308.25%2.28M

65.22%590.72K

128.03%1.61M

-20.52%294.67K

116.12%1.6M

-66.71%161.77K

Net PPE purchase and sale

----

-8,197.78%-149.78K

-5,106.04%-93.97K

----

---1.81K

Net investment purchase and sale

--0

-0.75%1.6M

308.21%1.2M

208.06%4.93M

1,350.16%2.37M

80.83%646.53K

128.03%1.61M

-20.52%294.67K

116.13%1.6M

-66.34%163.57K

Cash from discontinued investing activities

Investing cash flow

--0

-0.75%1.6M

308.21%1.2M

199.03%4.78M

1,308.25%2.28M

65.22%590.72K

128.03%1.61M

-20.52%294.67K

116.12%1.6M

-66.71%161.77K

Financing cash flow

Cash flow from continuing financing activities

316.96K

Net common stock issuance

--316.96K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--316.96K

----

--0

----

Net cash flow

Beginning cash position

321.35%924.6K

500.60%831.78K

498.49%1.29M

-60.24%215.19K

-3.15%153.33K

-35.21%219.44K

-71.28%138.49K

-60.24%215.19K

-19.36%541.17K

-65.59%158.32K

Current changes in cash

301.86%131.3K

15.42%92.65K

-491.34%-456.31K

370.06%1.07M

6,013.62%1.13M

63.40%-65.04K

157.27%80.27K

-29.03%-77.17K

-203.97%-396.84K

-123.71%-19.17K

Effect of exchange rate changes

91.60%-89

-75.11%167

-59.31%190

-98.59%998

-98.79%920

59.83%-1.06K

120.06%671

-42.06%467

11,129.48%70.86K

38,109.05%76.04K

End cash Position

588.57%1.06M

321.35%924.6K

500.60%831.78K

498.49%1.29M

-3.15%153.33K

-35.21%219.44K

-71.28%138.49K

-60.24%215.19K

Free cash flow

73.91%-185.66K

-1.31%-1.55M

-346.22%-1.66M

-93.10%-3.85M

-577.68%-1.24M

-32.95%-711.57K

-80.83%-1.53M

13.64%-371.83K

28.69%-2M

54.89%-182.74K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	71.69%-185.66K	-1.31%-1.55M	-346.22%-1.66M	-85.76%-3.7M	-532.51%-1.14M	-22.52%-655.77K	-80.83%-1.53M	13.64%-371.83K	28.76%-1.99M	55.33%-180.94K
Net income from continuing operations	54.12%-640.79K	-32.82%-1.61M	-140.12%-1.72M	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K
Operating gains losses	--0	-143.33%-51.53K	-104.47%-198	1,268.74%630.32K	7,876.31%483.76K	96.66%23.18K	411.69%118.95K	-10.57%4.43K	156.72%46.05K	143.97%6.07K
Depreciation and amortization	785.98%12.57K	13,714.29%12.57K	13,868.89%12.57K	93,960.00%28.22K	88,626.67%26.62K	--1.42K	--91	--90	--30	--30
Other non cash items	----	----	----	-22.59%85.77K	22.72%31.24K	-82.50%4.45K	-24.30%25.18K	-6.49%24.9K	-74.06%110.8K	-47.89%25.45K
Change In working capital	-64.75%192.15K	72.86%-171.83K	-172.69%-109.13K	-121.18%-114.41K	-192.84%-176.58K	294.56%545.11K	-39.94%-633.07K	-77.40%150.13K	484.74%540.13K	-11.86%190.2K
-Change in prepaid assets	-89.96%77.39K	53.49%-400.3K	133.06%100.03K	-113.79%-87.09K	-189.48%-39.95K	1,626.13%770.6K	-545.61%-860.65K	-93.65%42.92K	231.47%631.73K	-60.75%44.64K
-Change in payables and accrued expense	150.89%114.76K	0.39%228.46K	-295.09%-209.16K	70.17%-27.33K	-193.86%-136.63K	-341.14%-225.49K	171.32%227.58K	1,026.72%107.21K	-126.93%-91.6K	42.63%145.56K
Cash from discontinued investing activities
Operating cash flow	71.69%-185.66K	-1.31%-1.55M	-346.22%-1.66M	-85.76%-3.7M	-532.51%-1.14M	-22.52%-655.77K	-80.83%-1.53M	13.64%-371.83K	28.76%-1.99M	55.33%-180.94K
Investing cash flow
Cash flow from continuing investing activities	0	-0.75%1.6M	308.21%1.2M	199.03%4.78M	1,308.25%2.28M	65.22%590.72K	128.03%1.61M	-20.52%294.67K	116.12%1.6M	-66.71%161.77K
Net PPE purchase and sale	----	----	----	-8,197.78%-149.78K	-5,106.04%-93.97K	----	----	----	---1.81K	---1.81K
Net investment purchase and sale	--0	-0.75%1.6M	308.21%1.2M	208.06%4.93M	1,350.16%2.37M	80.83%646.53K	128.03%1.61M	-20.52%294.67K	116.13%1.6M	-66.34%163.57K
Cash from discontinued investing activities
Investing cash flow	--0	-0.75%1.6M	308.21%1.2M	199.03%4.78M	1,308.25%2.28M	65.22%590.72K	128.03%1.61M	-20.52%294.67K	116.12%1.6M	-66.71%161.77K
Financing cash flow
Cash flow from continuing financing activities	316.96K					0
Net common stock issuance	--316.96K	----	----	----	----	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--316.96K	----	----	----	----	--0	----	----	----	----
Net cash flow
Beginning cash position	321.35%924.6K	500.60%831.78K	498.49%1.29M	-60.24%215.19K	-3.15%153.33K	-35.21%219.44K	-71.28%138.49K	-60.24%215.19K	-19.36%541.17K	-65.59%158.32K
Current changes in cash	301.86%131.3K	15.42%92.65K	-491.34%-456.31K	370.06%1.07M	6,013.62%1.13M	63.40%-65.04K	157.27%80.27K	-29.03%-77.17K	-203.97%-396.84K	-123.71%-19.17K
Effect of exchange rate changes	91.60%-89	-75.11%167	-59.31%190	-98.59%998	-98.79%920	59.83%-1.06K	120.06%671	-42.06%467	11,129.48%70.86K	38,109.05%76.04K
End cash Position	588.57%1.06M	321.35%924.6K	500.60%831.78K	498.49%1.29M	498.49%1.29M	-3.15%153.33K	-35.21%219.44K	-71.28%138.49K	-60.24%215.19K	-60.24%215.19K
Free cash flow	73.91%-185.66K	-1.31%-1.55M	-346.22%-1.66M	-93.10%-3.85M	-577.68%-1.24M	-32.95%-711.57K	-80.83%-1.53M	13.64%-371.83K	28.69%-2M	54.89%-182.74K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data